NOV Inc. NOV
18.00 USD +0.32 (+1.81%)
At closeNov 11, 2026, 6:06 PM EST
17.95 -0.05 -0.28%
After hours · Nov 11, 6:06 PM ET
17.58 Day range 18.07
14.30 52-week range 21.93
- YTD
- +15.16%
- 1 year
- +14.72%
News
benzinga.com Citigroup Maintains Neutral on NOV, Lowers Price Target to $20 Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and lowers the price target from $21 to $20.
benzinga.com Barclays Maintains Underweight on NOV, Raises Price Target to $21 Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $20 to $21.
benzinga.com NOV Q3 2026 Earnings Call Transcript NOV (NYSE:NOV) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com NOV Q3 EPS $0.25, Inline, Sales $2.226B Beat $2.198B Estimate NOV (NYSE:NOV) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is a 127.27 percent increase over earnings of $0.11 per share from the same period last…- benzinga.com Citigroup Maintains Neutral on NOV, Lowers Price Target to $21 Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and lowers the price target from $22 to $21.
benzinga.com Barclays Maintains Underweight on NOV, Lowers Price Target to $20 Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and lowers the price target from $21 to $20.- benzinga.com Susquehanna Maintains Positive on NOV, Raises Price Target to $24 Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $22 to $24.
benzinga.com Susquehanna Maintains Positive on NOV, Lowers Price Target to $22 Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and lowers the price target from $24 to $22.- benzinga.com Citigroup Maintains Neutral on NOV, Raises Price Target to $22 Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and raises the price target from $20 to $22.
benzinga.com NOV Announces Supplemental Dividend Of $0.09 Per Share NOV Inc. (NYSE:NOV) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock, payable on June 26, 2026 to each stockholder of record…- benzinga.com Barclays Downgrades NOV to Underweight, Raises Price Target to $21 Barclays analyst David Anderson downgrades NOV (NYSE:NOV) from Equal-Weight to Underweight and raises the price target from $20 to $21.
benzinga.com RBC Capital Maintains Sector Perform on NOV, Raises Price Target to $22 RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Sector Perform and raises the price target from $21 to $22.- benzinga.com Evercore ISI Group Maintains In-Line on NOV, Raises Price Target to $22 Evercore ISI Group analyst James West maintains NOV (NYSE:NOV) with a In-Line and raises the price target from $19 to $22.
benzinga.com Susquehanna Maintains Positive on NOV, Raises Price Target to $24 Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $22 to $24.
benzinga.com NOV Q1 2026 Earnings Call Transcript 
benzinga.com Earnings Scheduled For April 27, 2026 - benzinga.com Morgan Stanley Maintains Equal-Weight on NOV, Raises Price Target to $20 Morgan Stanley analyst Daniel Kutz maintains NOV (NYSE:NOV) with a Equal-Weight and raises the price target from $18 to $20.
benzinga.com NOV Expects Q1 Revenue, Earnings To Fall Below Expectations Due To Middle East Conflict; Anticipates Q1 Revenue Of $2.05B, Operating Profit Of $47M, Adjusted EBITDA Of $177M NOV Inc. (NYSE:NOV) announced today that operational disruptions resulting from the war in the Middle East will cause first quarter 2026 revenue and earnings to be below prior guidance. On a…- benzinga.com RBC Capital Downgrades NOV to Sector Perform, Maintains Price Target to $21 RBC Capital analyst Keith Bachman downgrades NOV (NYSE:NOV) from Outperform to Sector Perform and maintains the price target from $21 to $21.
- benzinga.com Susquehanna Maintains Positive on NOV, Raises Price Target to $22 Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $21 to $22.
- benzinga.com NOV Plans To Roughly Double Capacity Of Subsea Flexible Pipe Manufacturing Facility In Açu, Brazil, Through $200M Investment Over Next Three Years NOV to roughly double the capacity of its manufacturing facility in Brazil over the next three years to support anticipated demand$200 million capital expansion positions NOV to capture expected…
benzinga.com The Analyst Verdict: NOV In The Eyes Of 11 Experts - benzinga.com Goldman Sachs Maintains Sell on NOV, Raises Price Target to $20 Goldman Sachs analyst Neil Mehta maintains NOV (NYSE:NOV) with a Sell and raises the price target from $17 to $20.
- benzinga.com BMO Capital Maintains Market Perform on NOV, Raises Price Target to $20 BMO Capital analyst Phillip Jungwirth maintains NOV (NYSE:NOV) with a Market Perform and raises the price target from $19 to $20.
benzinga.com Beyond The Numbers: 8 Analysts Discuss NOV Stock - benzinga.com Barclays Upgrades NOV to Equal-Weight, Raises Price Target to $20 Barclays analyst David Anderson upgrades NOV (NYSE:NOV) from Underweight to Equal-Weight and raises the price target from $15 to $20.
- benzinga.com Earnings Scheduled For February 4, 2026
- benzinga.com Demystifying NOV: Insights From 11 Analyst Reviews
- benzinga.com Susquehanna Maintains Positive on NOV, Raises Price Target to $20 Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $17 to $20.
- benzinga.com Piper Sandler Maintains Neutral on NOV, Raises Price Target to $17 Piper Sandler analyst Luke Lemoine maintains NOV (NYSE:NOV) with a Neutral and raises the price target from $14 to $17.
- benzinga.com Barclays Maintains Underweight on NOV, Raises Price Target to $15 Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $13 to $15.
- benzinga.com Citigroup Maintains Neutral on NOV, Raises Price Target to $17 Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and raises the price target from $16 to $17.
- benzinga.com NOV Sells Shepherd Power To Natura, Becomes Investor, Signs Supply Chain MOU To Support Advanced Nuclear Reactor Deployment; No Terms Disclosed NOV becomes investor in Natura Resources ("Natura") and appoints representative to Natura's Board of Directors in conjunction with the sale of Shepherd PowerNOV and Natura sign Memorandum of…
- benzinga.com NOV Inc. Names Jose Bayardo As New Chairman, President And CEO; Clay Williams Retires Effective Jan 1, 2026 NOV Inc. announced today that Clay Williams, Chairman and Chief Executive Officer will retire, and Jose Bayardo, NOV's current President and Chief Operating Officer, will succeed him and serve as…
- benzinga.com Armada Collaborates With NOV To Launch Beacon, Edge Device Integrated With Armada Edge Platform And Physically Deployed At Industrial Sites Armada, a leader in artificial intelligence at the edge, today announced a strategic collaboration with NOV (NYSE:NOV), a global leader in energy technology and industrial solutions, to deliver…
- benzinga.com Citigroup Maintains Neutral on NOV, Raises Price Target to $16 Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and raises the price target from $14 to $16.
benzinga.com A Look Into NOV Inc's Price Over Earnings - benzinga.com Barclays Maintains Underweight on NOV, Lowers Price Target to $13 Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and lowers the price target from $14 to $13.
- benzinga.com Goldman Sachs Maintains Sell on NOV, Raises Price Target to $14 Goldman Sachs analyst Neil Mehta maintains NOV (NYSE:NOV) with a Sell and raises the price target from $12 to $14.
- benzinga.com Barclays Maintains Underweight on NOV, Raises Price Target to $14 Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $11 to $14.
- benzinga.com RBC Capital Maintains Outperform on NOV, Raises Price Target to $19 RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and raises the price target from $17 to $19.
- benzinga.com NOV Q3 EPS $0.11 Misses $0.26 Estimate, Sales $2.176B Beat $2.141B Estimate NOV (NYSE:NOV) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.26 by 57.2 percent. This is a 66.67 percent decrease over earnings of $0.33 per share…
benzinga.com Earnings Scheduled For October 27, 2025 Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterly earnings at $0.54 per share on revenue of $4.15 billion.- benzinga.com Uncovering Potential: NOV's Earnings Preview
benzinga.com 6 Energy Stocks Lighting Up The Value Leaderboard Six energy stocks have climbed into the top 10% of Benzinga's value rankings over the past week. Here's what investors need to know.
benzinga.com These 3 Beaten-Down Oil Stocks Could Make A Big Comeback Three Oil & Gas Equipment stocks joined the top 10% value rankings this week. See NOA, NOV, and RNGR's week-on-week value percentile moves.- benzinga.com P/E Ratio Insights for NOV
- benzinga.com Breaking Down NOV: 9 Analysts Share Their Views
- benzinga.com Piper Sandler Maintains Neutral on NOV, Lowers Price Target to $14 Piper Sandler analyst Luke Lemoine maintains NOV (NYSE:NOV) with a Neutral and lowers the price target from $16 to $14.
- benzinga.com RBC Capital Maintains Outperform on NOV, Lowers Price Target to $18 RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and lowers the price target from $19 to $18.